Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,291 INR | -0.27% | +0.03% | -4.80% |
May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.80% | 1.18B | |
+16.31% | 42.32B | |
+15.86% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-11.94% | 6.58B | |
-8.87% | 5.73B | |
+14.28% | 5.51B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Laboratories : Unit Gains US FDA Nod for Heart Failure Treatment